Van Hulzen Asset Management’s Moderna MRNA Stock Holding History

Van Hulzen Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,044	Closed	-$367K	–	319
2022 Q4	$367K	Buy	+2,044	New	+$334K	0.04%	208
2022 Q2	–	Sell	-1,244	Closed	-$214K	–	313
2022 Q1	$214K	Sell	1,244 -3,820	-75%	-$643K	0.02%	283
2021 Q4	$1.29M	Buy	5,064 +3,695	+270%	+$1.08M	0.14%	104
2021 Q3	$527K	Buy	+1,369	New	+$505K	0.08%	148

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Van Hulzen Asset Management's MRNA Position: Q1 2023 in Review

Van Hulzen Asset Management sold out of Moderna (MRNA) in Q1 2023, closing a stake of 2,044 shares — an estimated $367K sold.

Van Hulzen Asset Management first reported a position in MRNA in Q3 2021 and held it in 4 quarters. The position peaked at $1.29M in Q4 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

Van Hulzen Asset Management reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
Van Hulzen Asset Management sold 2,044 Moderna shares in Q1 2023, an estimated $367K.
Van Hulzen Asset Management first reported a position in Moderna in Q3 2021 and held it in 4 quarters.
Van Hulzen Asset Management's Moderna position peaked at $1.29M in Q4 2021.
1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Van Hulzen Asset Management's 13F filing for Q1 2023, filed 28 Apr 2023.